Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Feb;99(2):221-7.
doi: 10.2105/AJPH.2007.131714. Epub 2008 Sep 17.

The promotion and marketing of oxycontin: commercial triumph, public health tragedy

Art Van Zee  1
Affiliations

The promotion and marketing of oxycontin: commercial triumph, public health tragedy

Art Van Zee. Am J Public Health. 2009 Feb.

Abstract

I focus on issues surrounding the promotion and marketing of controlled drugs and their regulatory oversight. Compared with noncontrolled drugs, controlled drugs, with their potential for abuse and diversion, pose different public health risks when they are overpromoted and highly prescribed. An in-depth analysis of the promotion and marketing of OxyContin illustrates some of the associated issues. Modifications of the promotion and marketing of controlled drugs by the pharmaceutical industry and an enhanced capacity of the Food and Drug Administration to regulate and monitor such promotion can have a positive impact on the public health.

PubMed Disclaimer

References

    1. “OxyContin Marketing Plan, 2002.” Purdue Pharma, Stamford, CN, 2002
    1. Cicero T, Inciardi J, Munoz A. Trends in abuse of OxyContin and other opioid analgesics in the United States: 2002–2004. J Pain 2005;6:662–672 - PubMed
    1. Oxycodone and OxyContin. Med Lett Drugs Ther 2001;43:80–81 - PubMed
    1. Hale ME, Fleischmann R, Salzman R, et al. Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in chronic back pain. Clin J Pain 1999;15:179–183 - PubMed
    1. Kaplan R, Parris WC, Citron MI, et al. Comparison of controlled-release and immediate-release oxycodone in cancer pain. J Clin Oncol 1998;16:3230–3237 - PubMed

LinkOut - more resources